Venous Thromboembolism Diagnosis And Management
44 researchers across 4 institutions
Research in venous thromboembolism (VTE) focuses on improving the diagnosis and management of blood clots in veins. Investigations explore novel diagnostic tools, including imaging techniques and biomarkers, to detect deep vein thrombosis and pulmonary embolism more accurately and efficiently. Studies also examine various treatment strategies, such as anticoagulation therapies and mechanical interventions, evaluating their effectiveness and potential side effects. This area encompasses retrospective analyses of patient data, prospective clinical trials, and systematic reviews to synthesize existing evidence and inform clinical practice guidelines. Understanding risk factors, patient stratification, and long-term outcomes after VTE events are also key components of this research.
The prevalence and impact of VTE are significant public health concerns, and research in this area holds particular relevance for Arkansas. Understanding health disparities and outcomes within the state’s diverse populations is crucial for developing targeted prevention and treatment strategies. This work can inform healthcare policy and management within Arkansas’s healthcare systems, potentially reducing the burden of VTE on patients and the economy. Examining the influence of factors such as trauma, emergency care access, and rural health challenges, which are prevalent in Arkansas, offers unique insights into VTE management in varied settings.
This research area draws upon expertise from numerous related fields, including health disparities and outcomes, trauma and emergency care, healthcare policy, and pharmacological studies. Engagement across multiple Arkansas institutions facilitates a broad approach to addressing complex questions in VTE diagnosis and management, fostering collaboration and diverse perspectives.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Michele Cottler‐Fox | UAMS | 42 | 6,673 | High Impact | |
| Huyen Tran | University of Arkansas | 30 | 3,911 | High Impact | |
| Aaron M. Wendelboe | UAMS | 27 | 6,907 | High Impact | |
| Zheng‐Yu Wang | UAMS | 24 | 2,317 | ||
| Mary B. Moore | UAMS | 22 | 2,158 | High Impact | |
| Michail N. Mavros | UAMS | 17 | 1,101 | ||
| Sonia T. Orcutt | UAMS | 16 | 1,377 | ||
| G.V.R.K. Sharma | University of Arkansas – Fort Smith | 15 | 908 | ||
| Hani Alturkmani | UAMS | 11 | 458 | ||
| Ronald D. Robertson | UAMS | 9 | 1,998 | ||
| Divyaswathi Citla Sridhar | UAMS | 7 | 631 | ||
| Lauren A. Johnson | UAMS | 7 | 154 | ||
| Anil Anandam | UAMS | 6 | 348 | ||
| Jeanette M. Ramos | UAMS | 6 | 95 | ||
| Ghassan Bachuwa | UAMS | 6 | 80 | ||
| Aashka Shah | UAMS | 5 | 94 | ||
| L. Ferguson | University of Arkansas | 4 | 419 | ||
| Rebecca Reif | UAMS | 4 | 49 | ||
| Divya Nayar | UAMS | 3 | 76 | ||
| Brian Koenen | UAMS | 3 | 22 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 3,444
- 2 Brigham and Women's Hospital 2,688
- 3 Massachusetts General Hospital 2,180
- 4 Cleveland Clinic 1,786
- 5 University of Michigan 1,737
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Venous Thromboembolism Diagnosis And Management.